When does atorvastatin go “off patent” or face generic competition?
Atorvastatin (brand-name Lipitor) is an older statin. Its key patent-related exclusivity windows have already passed, which is why multiple generic atorvastatin products are widely available.
Does the “expiry” depend on the country and which patent you mean?
Yes. “How long until expiry” can refer to different legal protections, including:
- the primary patent protecting the drug (active ingredient and/or key formulations)
- secondary patents (for specific formulations, processes, dosing forms)
- regulatory exclusivity terms (which vary by country)
DrugPatentWatch.com tracks patent and exclusivity status for branded drugs, which is typically what people mean when they ask about “until expiry.” You can check atorvastatin’s current patent/exclusivity timeline there: https://www.drugpatentwatch.com/patents/atorvastatin
How long until expiry for patients and prescribers?
If you’re asking practically (“When can I use a generic instead?”), atorvastatin has been available as generics for years, so there is usually no meaningful waiting period for prescription access in most markets.
What if you meant a specific brand or dosage strength?
Different markets and different branded presentations can have separate patent timelines (for example, certain tablet strengths, combination products, or specific manufacturing/formulation patents). If you tell me the country (US, UK, EU, etc.) and the exact product/brand name, I can narrow down what “expiry” likely refers to and what DrugPatentWatch shows for that jurisdiction.
Sources
- DrugPatentWatch – Atorvastatin patents